Citation Impact
Citing Papers
The immune paradox of sarcoidosis and regulatory T cells
2006
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Nasopharyngeal carcinoma
2005 Standout
A single-centre experience of post-renal transplant lymphoproliferative disorder
2003
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix
1993
EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS
1999
Pathways of T‐cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy
1997
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Post renal transplantation human herpesvirus 8‐associated lymphoproliferative disorder and Kaposi's sarcoma
2001
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
T-cell-receptor gene therapy
2002
Viral Infection in the Renal Transplant Recipient
2005
Acute graft-vs-host disease
2001
Amyloid diseases of the heart: current and future therapies
2012
Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas
2004
A listing of human tumor antigens recognized by T cells
2001
The TCL1 family of oncoproteins: co-activators of transformation
2005
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial
2002 Standout
Neurologic Complications of Plasma Cell Disorders
2004
Skin Cancers after Organ Transplantation
2003 Standout
Sarcoidosis
2013 Standout
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
2009 StandoutNobel
A listing of human tumor antigens recognized by T cells: March 2004 update
2004
Immunotherapy to reconstitute immunity to DNA viruses
2002
INTERFERON-?? TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RECIPIENTS OF SOLID ORGAN TRANSPLANTS1
1998
TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN THE CENTRAL NERVOUS SYSTEM OF A LUNG TRANSPLANT RECIPIENT USING ALLOGENEIC LEUKOCYTES1
1997
Graft-versus-host disease
2009 Standout
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Systemic amyloidosis
2015 Standout
Monoclonal antibodies as therapeutic agents for cancer
2004
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors
2008
Antigens for cancer immunotherapy
2008
Hematopoietic Stem-Cell Transplantation
2006 Standout
RISK FACTORS FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) IN PEDIATRIC KIDNEY TRANSPLANTATION: A REPORT OF THE NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT COOPERATIVE STUDY (NAPRTCS)1
2001
Cancer immunotherapy comes of age
2011 StandoutNature
Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy
1998
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)
2002
Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report
2004
Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors
1995
Infection in Solid-Organ Transplant Recipients
2007 Standout
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Sarcoidosis
2007 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Molecular Diagnosis of Epstein-Barr Virus-Related Diseases
2001
Mitoxantrone
1996
Changes in thymic function with age and during the treatment of HIV infection
1998 StandoutNature
Epstein–Barr Virus Infection
2000 Standout
Effect of hepatitis C virus infection on the risk of non‐Hodgkin's lymphoma: A meta‐analysis of epidemiological studies
2004
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Inflammatory Muscle Diseases
2015 Standout
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
2013
Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 high regulatory T cells in humans
2015 StandoutNobel
Regulatory T Cells and Human Disease
2020 StandoutNobel
Acute Myeloid Leukemia
2015 Standout
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis
2006
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter.
1989 StandoutNobel
Nuclear actin aggregation is a hallmark of anti-synthetase syndrome–induced dysimmune myopathy
2015
Stimulation of the Glucocorticoid-Induced TNF Receptor Family-Related Receptor on CD8 T Cells Induces Protective and High-Avidity T Cell Responses to Tumor-Specific Antigens
2010 StandoutNobel
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis
2007
Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.
1988
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
Human Tumor Antigens and Cancer Immunotherapy
2015
Current Trends in Diagnosis and Management of Cardiac Amyloidosis
2013
Antibody Production and In Vitro Behavior of CD27-Defined B-Cell Subsets: Persistent Hepatitis C Virus Infection Changes the Rules
2006
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
2003
Hepatitis C Virus (HCV) and Lymphomagenesis
2003
Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy
2005
T-cell depletion of HLA-identical transplants in leukemia
1991
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Course and outcome of hepatitis C
2002
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
1994
How I treat refractory and early relapsed acute myeloid leukemia
2015
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
2005 StandoutScience
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Post-Transplant Lymphoproliferative Disorders
2004
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe
2005
The Role of B7 Costimulation in CD4/CD8 T Cell Homeostasis
2000 StandoutNobel
Multiple Myeloma
2011 Standout
Anti–B-Cell Monoclonal Antibody Treatment of Severe Posttransplant B-Lymphoproliferative Disorder: Prognostic Factors and Long-Term Outcome
1998
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Diagnosis and Management of Posttransplant Lymphoproliferative Disorder in Solid‐Organ Transplant Recipients
2001
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study
2003
A single-centre experience of post-renal transplant lymphoproliferative disorder
2003
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.
2000
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of V. Leblond being referenced
Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis?
2007
Effectiveness of second-line treatment in AL amyloidosis patient's refractory to M-Dex
2011
Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
1995
Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia.
1998
Hepatitis C virus infection and lymphoproliferative diseases: Prospective study on 1,576 patients in France
2001
Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.
1995
Waldenström's macroglobulinaemia
2002
Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
1998
Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations
1996
Results of two randomized total body irradiation dose rates in 56 patients with acute non-lymphoblastic leukemia
1992
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma
1995
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients
2000
Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia
1991
A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis
1991
Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation
1994
IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIAS
1987
Autologous Stem Cell Transplantation (ASCT) Versus Oral Melphalan and High-Dose Dexamethasone in Patients with AL (Primary) Amyloidosis: Results of the French Multicentric Randomized Trial (MAG and IFM Intergroup).
2005
STEM CELL TRANSPLANTATION IN A PATIENT WITH LATE-ONSET NEMALINE MYOPATHY AND GAMMOPATHY
2008
High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients
1993